Preclinical Evaluation of Antimicrobial Nanodrugs
Translational medicine addresses the gap between research and the clinical application of new discoveries. To efficiently deliver new drugs to care centers, a preclinical evaluation, both in vitro and in vivo, is required to ensure that the most active and least toxic compounds are selected as well...
Main Author: | |
---|---|
Format: | eBook |
Language: | English |
Published: |
Cham
Springer International Publishing
2020, 2020
|
Edition: | 1st ed. 2020 |
Series: | Nanotechnology in the Life Sciences
|
Subjects: | |
Online Access: | |
Collection: | Springer eBooks 2005- - Collection details see MPG.ReNa |
Table of Contents:
- Preface
- 1. Antimicrobial screening, foundations and interpretation
- 2. Antimicrobial activity of nanomaterials, from selection to application
- 3. Synergy and antagonism, the criteria of the formulation
- 4. In vitro Nanotoxicity, towards the development of safe and effective treatments
- 5. ADMETox, bringing nanotechnology closer to Lipinski's rule of five
- 6. Antimicrobial nanotechnology in preventing the transmission of infectious disease
- 7. Nanotechnology in the discovery of new antimicrobial drugs: is a new scientific revolution possible?
- 8. Nanotechnology beyond the antibiosis
- Index.